Discovering signature genes and developing expression markers for blastema cells

Information

  • Research Project
  • 9658089
  • ApplicationId
    9658089
  • Core Project Number
    F32GM117806
  • Full Project Number
    5F32GM117806-03X1
  • Serial Number
    117806
  • FOA Number
    PA-14-149
  • Sub Project Id
  • Project Start Date
    4/25/2016 - 8 years ago
  • Project End Date
    4/24/2019 - 5 years ago
  • Program Officer Name
    MELILLO, AMANDA A
  • Budget Start Date
    4/25/2018 - 6 years ago
  • Budget End Date
    4/24/2019 - 5 years ago
  • Fiscal Year
    2018
  • Support Year
    03
  • Suffix
    X1
  • Award Notice Date
    4/24/2018 - 6 years ago
Organizations

Discovering signature genes and developing expression markers for blastema cells

? DESCRIPTION (provided by applicant): The objective of this three-year postdoctoral training program is to empower the applicant with the necessary skills and network to establish an independent laboratory in the United States studying regeneration in newts (salamanders). Newts are critical components of the regenerative research landscape due to their ability to replace complex body parts after loss. Limb regeneration is an important model in this regard. Central to newt limb regeneration is the formation of a blastema; a heterogeneous mass of cells that develop into the new limb. Despite its centrality, we have a minimal understanding of the blastema and lack any specific expression markers. The applicant will identify the genes and cis-regulatory elements that regulate blastema formation in the Iberian newt and develop fluorescent expression markers to identify blastema cell types in vivo. This will be accomplished through the following research plan. First, functionally relevant genomic regions will be sequenced and assembled by a combination of whole genome sequencing and selectively sequencing open chromatin (Aim 1). Second, using single-cell transcriptomics, the cell types contributing to the blastema at will be classified and marker genes identified. Additionally, by integrating this single-cell transcriptomic information with obtained genomic sequences, cis-regulatory elements that are over- or under- represented in blastema markers genes will be identified (Aim 2). Third, using CRISPR/Cas9 genome editing, transgenic newts expressing fluorescent blastema markers will be developed (Aim 3). The identified genes, cis-regulatory elements and transgenic newts will offer unprecedented knowledge and tools to further understand the regulation of regeneration, thereby enabling the applicant to begin a promising independent career in regeneration research.

IC Name
NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES
  • Activity
    F32
  • Administering IC
    GM
  • Application Type
    5
  • Direct Cost Amount
    8850
  • Indirect Cost Amount
  • Total Cost
    8850
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    859
  • Ed Inst. Type
  • Funding ICs
    NIGMS:8850\
  • Funding Mechanism
    TRAINING, INDIVIDUAL
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    KAROLINSKA INSTITUTE
  • Organization Department
  • Organization DUNS
    350582235
  • Organization City
    STOCKHOLM
  • Organization State
  • Organization Country
    SWEDEN
  • Organization Zip Code
    171 77
  • Organization District
    SWEDEN